EVGO's fourth-quarter 2024 results reflect a narrower loss, 35% revenue growth YoY and a significant boost in charging network revenues.

Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract. Shares rise in pre-market.

XENE reports a narrower-than-expected fourth-quarter 2024 loss. Its development programs for azetukalner in epilepsy and MDD are progressing well.

RCKT incurs a narrower-than-expected fourth-quarter 2024 loss. The company provides updates on its pipeline candidates.

PNW fourth-quarter earnings decrease year over year, while revenues increase. Total operating expenses also rise during the same period.

Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.

Intellia reports better-than-expected fourth-quarter 2024 results. The company provides updates on its pipeline candidates.

BEAM incurs a narrower-than-expected loss in the fourth quarter. The company remains focused on pipeline development.

LMND's Q4 2024 results reflect an increase in net earned premiums and an increase in investment income, offset by higher expenses.

DNLI reports a narrower-than-expected loss for the fourth quarter of 2024. Denali remains on track to submit a BLA for tividenofusp alfa for the...